Design, synthesis and biological evaluation of novel AhR agonists
10.16438/j.0513-4870.2024-0517
- VernacularTitle:新型AhR激动剂的设计、合成及活性研究
- Author:
Jian-min JIA
;
Ya-xian CAI
;
Zi-xing HAN
;
Jia-jia XU
;
Kai-ming CAI
;
Xiao-hui HU
- Publication Type:Research Article
- Keywords:
aryl hydrocarbon receptor;
agonist;
Tapinarof;
IFN-γ;
photochemical stability
- From:
Acta Pharmaceutica Sinica
2024;59(11):2997-3005
- CountryChina
- Language:Chinese
-
Abstract:
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that regulates gene expression in a range of cells, including immune and epithelial cells. AhR signaling plays important roles in the immune system in both health and disease states. Tapinarof is a first-in-class small-molecule topical therapeutic AhR modulating agent launched for the treatment of psoriasis. To improve the activity and chemical stability of Tapinarof, a series of 2-phenylchromen-4-one derivatives were designed, synthesized and evaluated as novel AhR agonists. Compounds 5a, 5c, 5e and 5f potently activated AhR with an EC50 value of 7, 9, 6 and 6 nmol·L-1, respectively, which are 10-14 fold more potent than Tapinarof. Compounds 5a and 5e exhibit comparable inhibitory effects on IFN-γ production as Tapinarof. Furthermore, compounds 5a-5f exhibited favorable photochemical stability compared to Tapinarof. The compounds may eventually serve as lead compounds for the development of new AhR agonists.